Benjamin P. Levy, MD, and Rasheda Persinger, AGNP-C, talk about the nurse practitioner’s interaction with the other providers and the patient who has non–small cell lung cancer in dealing with symptom control, treatment, toxicity management, and adherence; differences with targeted therapy, immunotherapy, are chemotherapy also are discussed.
